Pharmaceutical Two new product licensing agreements were announced yesterday: Anglo-Swedish drug major entered a deal with Dako Denmark A/S to collaborate on companion diagnostic tests for multiple AstraZeneca oncology projects, including biologics and small molecules, in various stages of discovery and development. Also, Alcon, the eye-care giant at the heart a full takeover accord by Swiss drug major Novartis (The Pharma Letter January 4), has acquired rights to two products from Sirion Therapeutics. Financial terms of neither transaction were revealed. 19 January 2010